Background: Granulomatous reaction to Pneumocystis jirovecii is a rare but well-known pathological finding encountered in the setting of immunosuppression, HIV infection being the most common cause. It can also potentially complicate the treatment of hematological malignancies, typically when drugs lowering the count and function of lymphocytes are used. Lung biopsy is considered the gold standard for the diagnosis of granulomatous P. jirovecii pneumonia, whereas the diffuse alveolar form is usually detected cytologically in bronchoalveolar lavage (BAL). Case: A female patient pursuing R-CHOP chemotherapy for the treatment of multiple hematological malignancies developed a rapidly progressing dyspnea. Chest CT scans revealed a worsening of a known infiltrative lung disease thought to be secondary to her chemotherapy. Alterations compatible with a drug-induced interstitial lung disease and well-formed focally necrotizing granulomas were observed on an open lung biopsy, but no microorganism was identified with special stains. Eventually, a granulomatous reaction to P. jirovecii was found in a BAL and allowed appropriate treatment with rapid improvement of the dyspnea. Conclusion: Because granulomas are tissue-bound structures, they are rarely described in BAL. This article describes the first reported cytological diagnosis of a granulomatous reaction to P. jirovecii and the potential diagnostic interest of such a peculiar finding.

Keywords:
Pneumocystis jirovecii, Granulomatous pneumonia, Granuloma, Bronchoalveolar lavage
1.
Sato M, Ito S, Ogura M, Kamei K, Miyairi I, Miyata I, Higuchi M, Matsuoka K: Atypical Pneumocystis jirovecii pneumonia with multiple nodular granulomas after rituximab for refractory nephrotic syndrome. Pediatr Nephrol 2013;28:145-149.
2.
Vassallo R, Standing JE, Limper AH: Isolated Pneumocystis carinii cell wall glucan provokes lower respiratory tract inflammatory responses. J Immunol 2000;164:3755-3763.
3.
Chang H, Shih LY, Wang CW, Chuang WY, Chen CC: Granulomatous Pneumocystis jirovecii pneumonia in a patient with diffuse large B-cell lymphoma: case report and review of the literature. Acta Haematol 2010;123:30-33.
4.
Gal AA, Plummer AL, Langston AA, Mansour KA: Granulomatous Pneumocystis carinii pneumonia complicating hematopoietic cell transplantation. Pathol Res Pract 2002;198:553-558.
5.
Teichmann LL, Woenckhaus M, Vogel C, Salzberger B, Schölmerich J, Fleck M: Fatal Pneumocystis pneumonia following rituximab administration for rheumatoid arthritis. Rheumatology (Oxford) 2008;47:1256-1257.
6.
Hugle B, Solomon M, Harvey E, James A, Wadhwa A, Amin R, Bell-Peter A, Benseler S: Pneumocystis jirovecii pneumonia following rituximab treatment in Wegener's granulomatosis. Arthritis Care Res (Hoboken) 2010;62:1661-1664.
7.
Hartel PH, Shilo K, Klassen-Fischer M, Neafie RC, Ozbudak IH, Galvin JR, Franks TJ: Granulomatous reaction to Pneumocystis jirovecii: clinicopathologic review of 20 cases. Am J Surg Pathol 2010;34:730-734.
8.
Totet A, Duwat H, Daste G, Berry A, Escamilla R, Nevez G: Pneumocystis jirovecii genotypes and granulomatous pneumocystosis. Med Mal Infect 2006;36:229-231.
9.
Oki Y, Kami M, Kishi Y, Ueyama JI, Honma S, Sugiyama T, Miyakoshi S, Kanda Y, Morinaga SI, Muto Y: Pneumocystis carinii pneumonia with an atypical granulomatous response in a patient with chronic lymphocytic leukemia. Leuk Lymphoma 2001;41:435-438.
10.
Lambrecht BN: Alveolar macrophage in the driver's seat. Immunity 2006;24:366-368.
11.
Steele C, Marrero L, Swain S, Harmsen AG, Zheng M, Brown GD, Gordon S, Shellito JE, Kolls JK: Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the dectin-1 β-glucan receptor. J Exp Med 2003;198:1677-1688.
12.
Zhang J, Zhu J, Imrich A, Cushion M, Kinane TB, Koziel H: Pneumocystis activates human alveolar macrophage NF-κB signaling through mannose receptors. Infect Immun 2004;72:3147-3160.
13.
Zissel G: Cellular activation in the immune response of sarcoidosis. Semin Respir Crit Care Med 2014;35:307-315.
14.
Fehrenbach H, Zissel G, Goldmann T, Tschernig T, Vollmer E, Pabst R, Müller-Quernheim J: Alveolar macrophages are the main source for tumour necrosis factor-α in patients with sarcoidosis. Eur Respir J 2003;21:421-428.
15.
Trisolini R, Paioli D, Patelli M, Cancellieri A, Squintani L: Bronchoalveolar lavage: intact granulomas in Mycobacterium avium pulmonary infection. Acta Cytol 2008;52:263-264.
16.
Hendricks MV, Crosby JH, Davis WB: Bronchoalveolar lavage fluid granulomas in a case of severe sarcoidosis. Am J Respir Crit Care Med 1999;160:730-731.
17.
Verma K, Sandhyamani S, Pande JN: Cytologic diagnosis of pulmonary tuberculosis by bronchoalveolar lavage. Acta Cytol 1983;27:211-212.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.